EN
HI
Strides Pharma Science Chart
Strides Pharma Science Share Key Metrics
Volume
1.01 L
Market Cap
10084.62 CR
LTQ@LTP
100@1094.10
ATP
1097.51
Var Margin
20.29 %
Circuit Range
874.4-1311.4
Delivery %
54.58 %
Value
11.09 CR
ASM/GSM
No
Market Lot
1
Summary
Strides Pharma Science share price is ₹1094.1 as of 2 Jul, 2026. The stock Strides Pharma Science intraday movement has stayed between ₹1087.20 and ₹1119.90, while on a 52-week basis,Strides Pharma Science price 52 week high is ₹1231.00 & its 52 week low is ₹768.65.
In terms of trading activity, Strides Pharma Science has recorded a volume of 101034 shares, The Strides Pharma Science has a market cap of ₹92172714 CR. The stock’s Average Traded Price (ATP) stands at ₹1097.51, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 100 @ ₹1094.10.
Strides Pharma Science operates within a circuit range of ₹874.40 – ₹1311.40, with a Value of ₹11.09 CR. The Delivery Percentage for the day is 54.58%. Additionally, Strides Pharma Science currently falls under the No framework, and trades with a market lot size of 1.
Strides Pharma Science Fundamentals
P/E Ratio
18.12
P/B Ratio
3.24
Div. Yield
0.46
Sector P/E
70.76
Sector P/B
3.21
Sec. Div. Yield
0.53
Strides Pharma Science Resistance and Support
Pivot 1095.03
Resistance
First Resistance
1113.56
Second Resistance
1134.23
Third Resistance
1152.76
Support
First Support
1074.36
Second Support
1055.83
Third Support
1035.16
Strides Pharma Science Corporate Actions
| Date | Agenda |
|---|---|
| 2026-05-18 | Audited Results & Final Dividend |
| 2026-01-30 | Quarterly Results |
| 2025-10-31 | Quarterly Results |
| 2025-07-29 | Quarterly Results |
| 2025-05-22 | Audited Results & Final Dividend |
| 2025-01-30 | Quarterly Results |
Strides Pharma Science News
Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Restructuring
Strides Pharma Science divested a majority stake in its wholly-owned subsidiary, Pivot Path Private Limited, to a consortium led by Ascent Capital for Rs. 100 crore. The transaction also includes Ascent Capital's primary infusion of Rs. 50 crore into Pivot Path to accelerate its growth. Post-transaction, Pivot Path will be reclassified as an Associate Company.
Jun 27 2026 16:02:09
Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Strides Pharma Science divested a majority stake in its wholly-owned subsidiary, Pivot Path, to a consortium led by Ascent Capital. Strides will realize ₹100 crore while retaining a 20% stake, with Pivot Path valued at ₹230 crore post-money.
Jun 27 2026 16:00:27
Read More
Strides Pharma Science Management
| Name | Position |
|---|---|
| Arun Kumar | Chairman |
| Kausalya Santhanam | Non Executive Independent Director |
Strides Pharma Science Similar Stocks
Marksans Pharma Ltd.
268.85
-3.96 (1.45%)
Viyash Scientific Ltd.
288.20
11.45 (4.14%)
Sanofi Consumer Healthcare India Ltd.
4607.60
10.60 (0.23%)
Shilpa Medicare Ltd.
570.75
-27.65 (4.62%)
Metropolis Healthcare Ltd.
541.60
1.45 (0.27%)
Akums Drugs & Pharmaceuticals Ltd.
630.85
7.70 (1.24%)
Sudeep Pharma Ltd.
844.35
-4.15 (0.49%)
Jupiter Life Line Hospitals Ltd.
1444.50
23.60 (1.66%)
Blue Jet Healthcare Ltd.
549.15
23.95 (4.56%)
Healthcare Global Enterprises Ltd.
633.95
6.85 (1.09%)
Strides Pharma Science FAQs
The Buying Price of Strides Pharma Science share is 1094.1 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Strides Pharma Science stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Strides Pharma Science, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Strides Pharma Science shares is 18.12. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Strides Pharma Science shares is 3.24. Useful to assess the stock's value relative to its book value.
To assess Strides Pharma Science’s valuation compare Sector P/E, P/B which are 70.76 & 3.21 with sector averages, along with growth rates and financial metrics.
The Market Cap of Strides Pharma Science is 10084.62 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Strides Pharma Science share price is 1231.00 & 768.65. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Strides Pharma Science belongs to the Healthcare sector.
Made for Traders.
Trusted by Investors.
Download FinX — trade confidently, invest
smarter, track everything.
